Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece
•Survival is poor in patients refractory to first-line lenalidomide (Len).•Limited real-world data on treatment patterns and outcomes exist in these patients.•Len-refractory patients commonly received proteasome-inhibitor and triplet regimens.•Survival times of optimal regimens were poor versus non-...
Saved in:
Published in | Clinical lymphoma, myeloma and leukemia Vol. 24; no. 7; pp. 468 - 477 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!